Literature DB >> 23512095

The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure.

Erberto Carluccio1, Frank Lloyd Dini, Paolo Biagioli, Rosanna Lauciello, Anca Simioniuc, Cinzia Zuchi, Gianfranco Alunni, Gianpaolo Reboldi, Mario Marzilli, Giuseppe Ambrosio.   

Abstract

AIMS: Although many transthoracic echocardiographic (TTE) measurements have been shown to predict outcome in heart failure (HF), whether incremental risk prediction is afforded by their combination is unknown. We developed a simple echocardiographic risk score of mortality in HF patients. METHODS AND
RESULTS: We performed TTE in 747 systolic HF patients followed-up for 34 ± 23 months. The Cox hazard model was used to evaluate the association between 14 TTE parameters and death. The Echo Heart Failure Score (EHFS) was derived by assigning the value of 1 to each independent predictor when present, and 0 when it was absent, and then by summing the number. The 3-year risk prediction improvement was tested by adding the EHFS to a model containing clinical predictors, and by calculating the C index and net reclassification improvement (NRI). Five baseline TTE variables (end-systolic volume index, left atrial volume index, mitral E-wave deceleration time, tricuspid annular peak systolic excursion, and pulmonary artery systolic pressure) remained independent predictors of mortality. The mortality rate (per 100 patients/year) significantly increased with EHFS ranging from 0 to 5 (EHFS = 0, 2.7%; 1, 5.2%; 2, 10.1%; 3, 13.7%, 4, 29.7%; 5, 36.9%; P < 0.0001). Patients with EHFS ≥3 had a mortality hazard ratio of 3.58 (95% confidence interval 2.74-4.78) compared with EHFS <3. Adding EHFS to the base model improved the C index (from 0.74 to 0.81, P < 0.0001), yielding a continuous NRI of 0.63 (P < 0.0001).
CONCLUSIONS: The EHFS, an easily obtainable echo score, improved risk prediction of death over traditional prognostic factors in systolic HF patients, and it may prove useful for risk stratification.

Entities:  

Keywords:  Echocardiography; Heart failure; Prognosis; Risk score

Mesh:

Year:  2013        PMID: 23512095     DOI: 10.1093/eurjhf/hft038

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  23 in total

Review 1.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 2.  Role of Echocardiography in the Evaluation of Left Ventricular Assist Devices: the Importance of Emerging Technologies.

Authors:  Luca Longobardo; Christopher Kramer; Scipione Carerj; Concetta Zito; Renuka Jain; Valentin Suma; Vinay Thohan; Nasir Sulemanjee; Frank X Downey; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

3.  Beyond clinical examination and natriuretic peptides: comprehensive quantification of congestion with ultrasound in ambulatory heart failure patients.

Authors:  Nicolas Girerd; Elke Platz
Journal:  Eur J Heart Fail       Date:  2019-02-18       Impact factor: 15.534

Review 4.  Update on the Practical Role of Echocardiography in Selection, Implantation, and Management of Patients Requiring Left Ventricular Assist Device Therapy.

Authors:  Aashish Katapadi; Matt Umland; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2022-08-19       Impact factor: 3.955

5.  Red cell distribution width predicts mid-term prognosis in patients hospitalized with acute heart failure: the RDW in Acute Heart Failure (RE-AHF) study.

Authors:  Remo Melchio; Gianluca Rinaldi; Elisa Testa; Alessia Giraudo; Cristina Serraino; Christian Bracco; Laura Spadafora; Andrea Falcetta; Stefano Leccardi; Alberto Silvestri; Luigi Fenoglio
Journal:  Intern Emerg Med       Date:  2018-10-01       Impact factor: 3.397

6.  The utility of biomarker risk prediction score in patients with chronic heart failure.

Authors:  Alexander E Berezin; Alexander A Kremzer; Yulia V Martovitskaya; Tatyana A Berezina; Tatyana A Samura
Journal:  Clin Hypertens       Date:  2016-03-11

7.  The utility of biomarker risk prediction score in patients with chronic heart failure.

Authors:  Alexander E Berezin; Alexander A Kremzer; Yulia V Martovitskaya; Tatyana A Samura; Tatyana A Berezina; Anthony Zulli; Jan Klimas; Peter Kruzliak
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 8.  Pulmonary Hypertension in Patients Eligible for Transcatheter Mitral Valve Repair: Prognostic Impact and Clinical Implications.

Authors:  Evin Yucel; Rasha Al-Bawardy; Philippe B Bertrand
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-10

9.  Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study.

Authors:  Stefano Coiro; Guillaume Porot; Patrick Rossignol; Giuseppe Ambrosio; Erberto Carluccio; Isabella Tritto; Olivier Huttin; Simon Lemoine; Nicolas Sadoul; Erwan Donal; Faiez Zannad; Nicolas Girerd
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

10.  Incremental Prognostic Value of Conventional Echocardiography in Patients with Acutely Decompensated Heart Failure.

Authors:  Fabio Luis de Jesus Soares; Janine Magalhães Garcia de Oliveira; Gabriel Neimann da Cunha Freire; Lucas Carvalho Andrade; Marcia Maria Noya-Rabelo; Luis Claudio Lemos Correia
Journal:  Arq Bras Cardiol       Date:  2017-11-27       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.